Rajiv Malik - Viatris President Director

VTRS Stock  USD 13.25  0.12  0.91%   

President

Rajiv Malik is President Director of Viatris
Age 63
Address 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317
Phone724 514 1800
Webhttps://www.viatris.com

Latest Insider Transactions

2024-09-12Disposed of 139681 shares @ 11.66View
2024-08-30Disposed of 50000 shares @ 12View
2024-08-28Disposed of 50000 shares @ 11.9View
2024-08-23Disposed of 100000 shares @ 11.75View
2024-08-21Disposed of 100000 shares @ 11.75View
2024-06-13Disposed of 85660 shares @ 10.52View

Rajiv Malik Latest Insider Activity

Tracking and analyzing the buying and selling activities of Rajiv Malik against Viatris stock is an integral part of due diligence when investing in Viatris. Rajiv Malik insider activity provides valuable insight into whether Viatris is net buyers or sellers over its current business cycle. Note, Viatris insiders must abide by specific rules, including filing SEC forms every time they buy or sell Viatris'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Viatris Management Efficiency

The company has return on total asset (ROA) of 0.0248 % which means that it generated a profit of $0.0248 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0434) %, meaning that it created substantial loss on money invested by shareholders. Viatris' management efficiency ratios could be used to measure how well Viatris manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0 in 2024. Return On Capital Employed is likely to drop to 0.02 in 2024. At this time, Viatris' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 36.4 B in 2024, whereas Net Tangible Assets are likely to drop (11.3 B) in 2024.
Viatris currently holds 18.37 B in liabilities with Debt to Equity (D/E) ratio of 1.07, which is about average as compared to similar companies. Viatris has a current ratio of 1.43, which is within standard range for the sector. Note, when we think about Viatris' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Stephen CareyANI Pharmaceuticals
53
Ganadhish KamatDr Reddys Laboratories
57
Charles LickfoldCatalent
50
Trish HuntCatalent
54
Steven FasmanCatalent
57
Tom PEngCatalent
56
Ricky HopsonCatalent
48
Scott GuntherCatalent
52
Aristippos GennadiosCatalent
58
MPharm MSDr Reddys Laboratories
61
Wetteny JosephCatalent
48
Saumen ChakrabortyDr Reddys Laboratories
58
Jonathan ArnoldCatalent
54
David GaffinAlkermes Plc
52
Michael LandineAlkermes Plc
70
Alessandro MaselliCatalent
52
Ricardo PravdaCatalent
48
The company operates in four segments Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Viatris operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 37000 people. Viatris (VTRS) is traded on NASDAQ Exchange in USA. It is located in 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 and employs 32,000 people. Viatris is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Viatris Leadership Team

Elected by the shareholders, the Viatris' board of directors comprises two types of representatives: Viatris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Viatris. The board's role is to monitor Viatris' management team and ensure that shareholders' interests are well served. Viatris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Viatris' outside directors are responsible for providing unbiased perspectives on the board's policies.
Melissa Trombetta, Head Relations
Andrew Enrietti, Chief Officer
Anthony Mauro, President Markets
Theodora Mistras, Chief Officer
David Bayles, Chief Officer
Sanjeev Sethi, Chief Officer
Ramkumar Rayapureddy, Chief Officer
Paul Campbell, Senior Officer
Rajiv Malik, President Director
PharmD MBA, Chief Officer
Brian Roman, Global Counsel
Philippe Martin, Chief Officer
Derek Glover, Chief Officer
Scott Smith, CEO Director
Jeffrey MMS, President Division
Menassie MBA, President Markets
Robert Coury, Ex Chairman
Lara Ramsburg, Chief Officer
Sanjeev Narula, Chief Officer
Jennifer Mauer, Head Brand
Michael Goettler, CEO Director

Viatris Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Viatris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Viatris Stock Analysis

When running Viatris' price analysis, check to measure Viatris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viatris is operating at the current time. Most of Viatris' value examination focuses on studying past and present price action to predict the probability of Viatris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viatris' price. Additionally, you may evaluate how the addition of Viatris to your portfolios can decrease your overall portfolio volatility.